The topic of this year’s ASMS Sanibel Conference is Characterization of Protein Therapeutics by Mass Spectrometry. It is a great fit for us to talk about our Antibody Protein Sequencing Service.
Built on the superior Novor de novo sequencing engine, we are developing an automated protein sequencing platform to help speed up antibody drug development. The antibody protein is first digested by multiple enzymes. The resulting peptides are then measured by high resolution LC-MS/MS. The spectra are de novo sequenced and the target antibody protein sequence is automatically assembled using a reference antibody protein.
Antibody protein sequencing technology is particularly useful when cDNA or the original cell line is not available. You will have your money back if we cannot deliver the report confidently.
Please talk to us for service and technology detail.
As a side note, send in your monoclonal antibody samples before the end of February and mention the promo code, ASMSSANIBEL, we will get your first antibody sequenced half price.
Newsletter for All Things Protein Sequencing
Breakthrough Bispecific Antibody R&D Techniques, Apr 20 11:00am EST.
Talk to Our Scientists.
We Have Sequenced 5000+ Antibodies and We Are Eager to Help You.
Through next generation protein sequencing, Rapid Novor enables reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and developed the first recombinant polyclonal antibody diagnostics.
Talk to Our Scientists.
We Have Sequenced 5000+ Antibodies and We Are Eager to Help You.
Through next generation protein sequencing, Rapid Novor enables timely and reliable discovery and development of novel reagents, diagnostics, and therapeutics. Thanks to our Next Generation Protein Sequencing and antibody discovery services, researchers have furthered thousands of projects, patented antibody therapeutics, and ran the first recombinant polyclonal antibody diagnostics